S&P 500
765.61
-0.74%
DOW
514.02
-0.67%
NASDAQ
736.53
-1.07%
Russell
280.02
-0.69%
VIX
17.08
+1.37%
FTSE
47.27
-0.11%
Nikkei
96.83
-1.12%
BTC
83,486.01
-1.26%
ETH
2,680.94
-0.18%
Gold
377.91
-3.94%
Oil
150.01
+1.13%
Silver
54.95
-5.49%
S&P 500
765.61
-0.74%
DOW
514.02
-0.67%
NASDAQ
736.53
-1.07%
Russell
280.02
-0.69%
VIX
17.08
+1.37%
FTSE
47.27
-0.11%
Nikkei
96.83
-1.12%
BTC
83,486.01
-1.26%
ETH
2,680.94
-0.18%
Gold
377.91
-3.94%
Oil
150.01
+1.13%
Silver
54.95
-5.49%
Stock
Ti
News
Markets
Stocks
Screener
Calendar
Watchlist
Loading...
Home
/
Stocks
/
TOVX
/
News
TOVX
AMEX · Biotechnology
Theriva Biologics Inc
Penny Stocks
Biotech Stocks
Healthcare Stocks
$0.22
0.00 (-1.86%)
☆ Watch
As of Sep 28, 10:42 PM ET ·
Overview
Earnings
Forecast
Financials
News
Peers
TOVX News
1 articles
Theriva Biologics Surges on Phase 1 Cancer Data, But Risks Remain
TOVX surged 74.6% on Phase 1 VCN-01 data showing survival and biomarker signals in head-and-neck cancer, but the jump is not based on approval or revenue.
Markets
Jun 11
↑